[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE3676248D1 - Ubidecarenon enthaltende arzneimittel. - Google Patents

Ubidecarenon enthaltende arzneimittel.

Info

Publication number
DE3676248D1
DE3676248D1 DE8686900772T DE3676248T DE3676248D1 DE 3676248 D1 DE3676248 D1 DE 3676248D1 DE 8686900772 T DE8686900772 T DE 8686900772T DE 3676248 T DE3676248 T DE 3676248T DE 3676248 D1 DE3676248 D1 DE 3676248D1
Authority
DE
Germany
Prior art keywords
ubidecarenon
products containing
medicinal products
medicinal
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686900772T
Other languages
English (en)
Inventor
Franco Pozzi
Antonio Longo
Angelo Carenzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Application granted granted Critical
Publication of DE3676248D1 publication Critical patent/DE3676248D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
DE8686900772T 1985-02-01 1986-01-31 Ubidecarenon enthaltende arzneimittel. Expired - Fee Related DE3676248D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT19353/85A IT1191608B (it) 1985-02-01 1985-02-01 Composizione farmaceutica e forme farmaceutiche che la contengono
PCT/EP1986/000046 WO1986004503A1 (en) 1985-02-01 1986-01-31 Pharmaceutical composition containing ubidecarenone

Publications (1)

Publication Number Publication Date
DE3676248D1 true DE3676248D1 (de) 1991-01-31

Family

ID=11156982

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686900772T Expired - Fee Related DE3676248D1 (de) 1985-02-01 1986-01-31 Ubidecarenon enthaltende arzneimittel.

Country Status (6)

Country Link
US (1) US4869900A (de)
EP (1) EP0211023B1 (de)
JP (1) JPS62501908A (de)
DE (1) DE3676248D1 (de)
IT (1) IT1191608B (de)
WO (1) WO1986004503A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524421D0 (en) * 1985-10-03 1985-11-06 Boots Co Plc Therapeutic agents
CH668553A5 (de) * 1987-02-02 1989-01-13 Mepha Ag Arzneimittel mit verzoegerter wirkstofffreisetzung.
CH680072A5 (de) * 1989-10-27 1992-06-15 Nestle Sa
US6933286B2 (en) 1991-03-19 2005-08-23 R. Martin Emanuele Therapeutic delivery compositions and methods of use thereof
US7202225B1 (en) 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof
US20020123476A1 (en) * 1991-03-19 2002-09-05 Emanuele R. Martin Therapeutic delivery compositions and methods of use thereof
US6461593B1 (en) * 1992-02-19 2002-10-08 Biomedical And Clinical Research Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease
AU5832794A (en) * 1993-01-06 1994-08-15 T.S. Consult Aps Medium comprising a pharmacological/biological active substance
ES2074395B1 (es) * 1993-02-25 1996-03-01 Lifepharma Srl Composicion farmaceutica o dietetica de elevada actividad antioxidante en las patologias cardiovasculares y/o hepaticas.
IT1263840B (it) * 1993-03-30 1996-09-04 Giuseppe Furiosi Formulazioni orali di ubidecarenone in forma di capsule
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
DE69431959T2 (de) * 1993-10-15 2003-11-06 Cytrx Corp Therapeutische abgabesysteme und verfahren für ihre verwendung
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
CN1216636C (zh) 1996-08-30 2005-08-31 派普泰克有限公司 肽缓释组合物
WO1998056368A1 (en) * 1997-06-09 1998-12-17 Board Of Regents, The University Of Texas System Superiority of formulations containing coenzyme q10 in coconut oil
US6503483B2 (en) * 1997-06-12 2003-01-07 C.S. Bioscience, Inc. Dental formulation
DE19753108A1 (de) * 1997-11-29 1999-08-05 Wella Ag Mittel zur Erhöhung der Formbarkeit und des Glanzes von Haaren
FR2775597B1 (fr) * 1998-03-04 2001-04-20 Gattefosse Ets Sa Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication
US6200550B1 (en) 1998-12-11 2001-03-13 Q-Pharma, Inc. Oral care compositions comprising coenzyme Q10
DE19859045A1 (de) * 1998-12-21 2000-06-29 Fresenius Pharma Austria Gmbh Emulsion vom Typ Öl in Wasser mit Schutzwirkung gegen Peroxidationsschäden an menschlichen Organen, deren Herstellung und Verwendung
US6740338B1 (en) 2000-01-20 2004-05-25 Raj K. Chopra Reduced form of Cenzyme Q in high bioavailability stable oral dosage form
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
DE10046541A1 (de) * 2000-09-19 2002-03-28 Knoll Ag Mechanisch stabile darreichungsformen, enthaltend Ubichinone
GB0029843D0 (en) * 2000-12-07 2001-01-24 Univ Belfast Drug delivery system
US6300377B1 (en) * 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities
JP4567945B2 (ja) * 2003-01-17 2010-10-27 太陽化学株式会社 ユビデカレノン製剤
US20050260752A1 (en) * 2003-04-01 2005-11-24 Wilding Martin G Culture medium containing enhancers of oxidative phosphorylation
US20050074444A1 (en) * 2003-10-01 2005-04-07 Papas Andreas M. Coenzyme Q10 treatment for cystic fibrosis
TW200524541A (en) * 2003-11-17 2005-08-01 Cargill Inc Lecithin-containing granular compositions and methods of their preparation
AU2006235633A1 (en) * 2005-04-14 2006-10-19 Jarrow Formulas, Inc. Dietary supplement formulations for improved delivery of coenzyme Q10 and methods of administration
US8252326B2 (en) * 2005-06-01 2012-08-28 Catalent Australia Pty Ltd. Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10
KR100754953B1 (ko) 2005-09-14 2007-09-04 주식회사 대웅 유비데카레논을 함유한 가용화물, 액상 제제 및 그 제조 방법
KR100859781B1 (ko) 2007-03-26 2008-09-24 (주)미토콘 유비데카레논-함유 약학 조성물
KR100790957B1 (ko) 2007-09-06 2008-01-04 영남대학교 산학협력단 코-엔자임 ｑ 경구용 고형제제 조성물
EP2544663B1 (de) 2010-03-12 2018-01-03 Berg LLC Intravenöse formulierung aus dem coenzym q10 (coq10) und verwendungsverfahren dafür
CN110200910B (zh) * 2019-06-17 2022-04-19 北京中超海奇科技有限公司 一种辅酶q10透明水分散液的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525350A (en) * 1975-02-20 1985-06-25 The New England Institute, Inc. Methods of stimulating host defense system with coenzymes Q4 to Q.sub.1
JPS597685B2 (ja) * 1978-10-06 1984-02-20 理研ビタミン株式会社 ビタミン製剤の製造法
JPS5618914A (en) * 1979-07-25 1981-02-23 Eisai Co Ltd Ubidecarenone composition having good absorbability
JPS5665817A (en) * 1979-10-31 1981-06-03 Teikoku Chem Ind Corp Ltd Vitamin k injection
JPS58113127A (ja) * 1981-12-28 1983-07-05 Ajinomoto Co Inc ユビデカレノン含有水性液
DE3225706C2 (de) * 1982-07-09 1984-04-26 A. Nattermann & Cie GmbH, 5000 Köln Flüssige Wirkstofformulierungen in Form von Konzentraten für Mikroemulsionen
JPS601124A (ja) * 1983-06-16 1985-01-07 Eisai Co Ltd ユビデカレノン含有リポソ−ム被覆体
JPS6025918A (ja) * 1983-07-25 1985-02-08 Ajinomoto Co Inc 脂溶性薬物含有水性液
EP0366156B1 (de) * 1984-01-28 1995-01-11 Roshdy Dr. Ismail Mittel zur Behandlung von Erkrankungen der Venen und des Analbereichs
JPS61172814A (ja) * 1985-01-25 1986-08-04 Ss Pharmaceut Co Ltd 安定な低溶血性ビタミンｅ注射液

Also Published As

Publication number Publication date
WO1986004503A1 (en) 1986-08-14
EP0211023B1 (de) 1990-12-19
JPS62501908A (ja) 1987-07-30
IT8519353A0 (it) 1985-02-01
US4869900A (en) 1989-09-26
EP0211023A1 (de) 1987-02-25
IT1191608B (it) 1988-03-23

Similar Documents

Publication Publication Date Title
DE3676248D1 (de) Ubidecarenon enthaltende arzneimittel.
DE3679115D1 (de) Tablettenverpackung.
DE3780223D1 (de) Arzneimittel mit gesteuerter freisetzung.
DE3689384D1 (de) Arzneimittel zur topischen Anwendung.
DE3576276D1 (de) Phenothiazine enthaltende arzneimittel.
DE3676515D1 (de) Intranasal applizierbare pharmazeutische puder.
DE3580304D1 (de) Arzneimittel.
NO863029D0 (no) Farmasoeytisk doseringsenhet.
NO875419L (no) Blandinger for farmasoeytisk tape.
FI862590A0 (fi) Farmaceutiska produkter.
FI850455A0 (fi) Farmaceutiska produkter.
IT1213453B (it) Composizione farmaceutica.
DE3682960D1 (de) Pharmazeutische praeparate.
FI875167A (fi) Kallvalsad bandstaolprodukt.
NO874193D0 (no) Farmasoeytiske preparater.
DE3763519D1 (de) Heilnahrungsmittel.
DK52086D0 (da) Farmaceutiske praeparater indeholdende ergotalkaloider
ES297038Y (es) Tableta farmaceutica.
FI875616A0 (fi) Farmaceutiska blandningar.
DE3781045D1 (de) Antirheumatisches arzneimittel.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
NO882264L (no) Legemiddelpakning.
IT8520591A0 (it) Formulazione farmaceutica.
DE3889327D1 (de) Platinkomplexe enthaltende arzneimittel.
DE3673801D1 (de) Bis-dioxopiperazinabkoemmlinge und arzneimittel daraus.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee